Skip to content

Clinical trials

Phase 2 Chronic Limb-Threatening Ischemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Chronic Limb-Threatening Ischemia Phase: Phase 2 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20072
20082
20101
20121
20132
20141
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AnGes USA, Inc.4
FoxHollow Technologies1
Helixmith Co., Ltd.1
Hemostemix1
Juventas Therapeutics, Inc.1
Lifecells, LLC.1
Ochsner Health System1
Southern Arizona Vascular Institute1
TCA Cellular Therapy1
Vericel Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Chronic Limb-Threatening Ischemia13
Peripheral Vascular Diseases8
Peripheral Arterial Disease5
Ischemia3
Arterial Occlusive Diseases2
Vascular Diseases2
Ulcer1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.